Dr. Joy Wolfram holds an Associate Professor position at the University of Queensland in Australia. She also holds an affiliate faculty position in the Department of Nanomedicine at the Houston Methodist in Texas. She received her bachelors and masters degrees in biology from the University of Helsinki in Finland. In 2016, she completed her Ph.D. in Nanoscience and Technology at the University of Chinese Academy of Sciences in Beijing, China. 

She has authored over 60 publications and received more than 30 scientific awards from seven different countries. She was included in the Amgen Scholars Ten to Watch List, which highlights the best and brightest up-and-comers in science and medicine across 42 countries. She has developed several nanoparticles for the treatment of various diseases, including cancer. Her goal is to bring new nanomedicines with increased therapeutic efficacy and safety to the clinic. Her mission is also to inspire and support underrepresented minorities in science. She is actively involved in community outreach and scientific education.

The focus of Dr. Wolfram's research is on the development of synthetic and biological nanotherapeutics for the treatment of life-threatening diseases, such as cancer and tissue injury.